Can Financial Incentives Improve Patient Compliance with Optn Live Kidney Donor Follow-Up Policy? Results of a Randomized Controlled Trial
Johns Hopkins, Baltimore, MD
Meeting: 2019 American Transplant Congress
Abstract number: B166
Session Information
Session Name: Poster Session B: Kidney Donor Selection / Management Issues
Session Type: Poster Session
Date: Sunday, June 2, 2019
Session Time: 6:00pm-7:00pm
Presentation Time: 6:00pm-7:00pm
Location: Hall C & D
*Purpose: The Organ Procurement and Transplantation Network (OPTN) requires transplant hospitals to monitor live kidney donors (LKDs) for 2 years post-donation. However, the majority (57%) of transplant hospitals have failed to meet nationally-mandated thresholds (Henderson AJT, 2017). We sought to test the effectiveness of using small financial incentives to increase patient compliance with LKD follow-up in a randomized controlled trial (RCT).
*Methods: We are conducting an ongoing two-arm RCT of LKDs who undergo donor nephrectomy. Using block randomization, LKDs are assigned to the intervention ($25 gift card at time of each follow-up) or control arm (standard of care) upon discharge from their initial LKD hospitalization. Follow-up compliance is tracked over time. We present preliminary 6-month results, using Fisher’s exact test to assess the statistical significance of the difference in compliant follow-up between study arms.
*Results: Among 35 LKDs who underwent nephrectomy from 3/2017-12/2017, 19 were assigned to the intervention arm and 16 were assigned to the control arm. The majority of LKDs (N=27) were Caucasian, with a median age of 48.5 (interquartile range: 36.2-59.0) and no differences between study arms (p>0.1). More LKDs in the intervention arm were compliant with 6-month follow-up (N=15/19; 79%) compared to the control arm (N=10/16; 63%) (Figure), although these differences did not reach statistical significance (p=0.5).
*Conclusions: In a preliminary analysis of this ongoing RCT, we detected a tendency towards higher rates of 6-month compliance among LKDs who received financial incentivization compared to those who received standard of care.
To cite this abstract in AMA style:
Henderson M, Waldram M, DiBrito S, Thomas A, Ammary FAl, Ottman S, Massie A, Wang JGaronzik, Segev D. Can Financial Incentives Improve Patient Compliance with Optn Live Kidney Donor Follow-Up Policy? Results of a Randomized Controlled Trial [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/can-financial-incentives-improve-patient-compliance-with-optn-live-kidney-donor-follow-up-policy-results-of-a-randomized-controlled-trial/. Accessed November 22, 2024.« Back to 2019 American Transplant Congress